ferumoxytol- and gadolinium-labeled MRI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ferumoxytol- and gadolinium-labeled MRI, covering 2023-09-07 to 2023-09-07. Get the full timeline:
Most recent: Clinical Trial Update: Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors [Phase 2]